首页 > 最新文献

CVIR Endovascular最新文献

英文 中文
Provocative mesenteric angiography for occult gastrointestinal bleeding: a systematic review. 隐蔽性胃肠道出血的诱发性肠系膜血管造影:一项系统综述。
IF 1.2 Pub Date : 2023-08-17 DOI: 10.1186/s42155-023-00386-7
Siddhi Hegde, Patrick D Sutphin, Omar Zurkiya, Sanjeeva P Kalva

Occult gastrointestinal bleeding (GIB) is a challenge for physicians to diagnose and treat. A systematic literature search of the PubMed and Embase databases was conducted up to January 1, 2023. Eligible studies included primary research studies with patients undergoing provocative mesenteric angiography (PMA) for diagnosis or localization of occult GIB. Twenty-seven articles (230 patients) were included in the review. Most patients (64.8%) presented with lower GIB. The average positivity rate for provocative angiography was 48.7% (58% with heparin and 46.7% in thrombolytics). Embolization was performed in 46.4% of patients, and surgical management was performed in 37.5%. Complications were rare. PMA can be an important diagnostic and treatment tool but studies with high-level evidence and standardized protocols are needed to establish its safety and optimal use.

隐匿性胃肠道出血(GIB)的诊断和治疗对医生来说是一个挑战。到2023年1月1日,对PubMed和Embase数据库进行了系统的文献检索。符合条件的研究包括对接受激发性肠系膜血管造影(PMA)诊断或定位隐匿性GIB的患者进行的初步研究。27篇文章(230例患者)纳入综述。大多数患者(64.8%)表现为较低的GIB。刺激血管造影的平均阳性率为48.7%(肝素组为58%,溶栓组为46.7%)。46.4%的患者进行了栓塞治疗,37.5%的患者进行了手术治疗。并发症很少见。PMA可作为一种重要的诊断和治疗工具,但需要有高水平证据和标准化方案的研究来确定其安全性和最佳使用。
{"title":"Provocative mesenteric angiography for occult gastrointestinal bleeding: a systematic review.","authors":"Siddhi Hegde, Patrick D Sutphin, Omar Zurkiya, Sanjeeva P Kalva","doi":"10.1186/s42155-023-00386-7","DOIUrl":"10.1186/s42155-023-00386-7","url":null,"abstract":"<p><p>Occult gastrointestinal bleeding (GIB) is a challenge for physicians to diagnose and treat. A systematic literature search of the PubMed and Embase databases was conducted up to January 1, 2023. Eligible studies included primary research studies with patients undergoing provocative mesenteric angiography (PMA) for diagnosis or localization of occult GIB. Twenty-seven articles (230 patients) were included in the review. Most patients (64.8%) presented with lower GIB. The average positivity rate for provocative angiography was 48.7% (58% with heparin and 46.7% in thrombolytics). Embolization was performed in 46.4% of patients, and surgical management was performed in 37.5%. Complications were rare. PMA can be an important diagnostic and treatment tool but studies with high-level evidence and standardized protocols are needed to establish its safety and optimal use.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10037192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: a sub-analysis of the POPCORN registry. 第一代高剂量和低剂量药物包覆球囊在股腘动脉疾病中的应用:POPCORN登记的亚分析
IF 1.2 Pub Date : 2023-08-10 DOI: 10.1186/s42155-023-00390-x
Masahiko Fujihara, Mitsuyoshi Takahara, Yoshimitsu Soga, Osamu Iida, Daizo Kawasaki, Yusuke Tomoi, Yoshinori Tsubakimoto, Kenji Ogata, Eiji Karashima, Taku Kato, Yohei Kobayashi, Nobuhito Kaneko, Shinya Sasaki, Kei Ichihashi

Background: Drug-coated balloons (DCBs) have significantly changed endovascular therapy (EVT) for femoropopliteal artery (FPA) disease, in terms of the expansion of indications for EVT for symptomatic lower extremity arterial disease (LEAD). However, whether there is a difference in the performance among individual DCBs has not yet been fully discussed. The present sub-analysis of real-world data from a prospective trial of first-generation DCBs compared the clinical outcomes between high- and low-dose DCBs using propensity score matching methods. The primary endpoint was the restenosis-free and revascularization-free rates at 1 year.

Results: We compared 592 pairs matched for patient and lesion characteristics using propensity score matching among a total of 2,507 cases with first-generation DCBs (592 and 1,808 cases in the Lutonix low-dose and In.PACT Admiral high-dose DCB groups, respectively). There were no differences in patient/lesion characteristics, procedural success rates, or complications between the two groups. First-generation low-dose DCB had significantly lower patency (73.3% [95% confidence interval, 69.6%-77.3%] in the low-dose DCB group versus 86.2% [84.1%-88.3%] in the high-dose DCB group; P < 0.001) and revascularization-free (84.9% [81.9%-88.1%] versus 92.5% [90.8%-94.1%]; P < 0.001) rates. Chronic kidney disease on dialysis, cilostazol use, anticoagulant use, and severe calcification had a significant interaction effect in the association (all P < 0.05).

Conclusions: EVT to FPA with first-generation DCBs had inferior low-dose patency outcomes as compared with high-dose outcomes in the present cohort.

Level of evidence: Sub analysis of a prospective multicenter study.

背景:药物包被气球(DCBs)显著改变了股腘动脉(FPA)疾病的血管内治疗(EVT),扩大了EVT治疗症状性下肢动脉疾病(LEAD)的适应症。然而,各个dcb之间的性能是否存在差异还没有得到充分的讨论。本亚分析来自第一代dcb前瞻性试验的真实数据,使用倾向评分匹配方法比较了高剂量和低剂量dcb的临床结果。主要终点是1年内无再狭窄和无血运重建率。结果:我们比较了592对患者和病变特征匹配使用倾向评分匹配的2507例第一代DCBs(592例和1808例Lutonix低剂量和in)。分别为海军上将高剂量DCB组)。两组在患者/病变特征、手术成功率或并发症方面没有差异。第一代低剂量DCB的通畅率明显较低(低剂量DCB组为73.3%[95%可信区间,69.6%-77.3%],而高剂量DCB组为86.2% [84.1%-88.3%];结论:在本队列中,与高剂量结果相比,第一代DCBs的EVT至FPA的低剂量通畅结果较差。证据水平:一项前瞻性多中心研究的亚分析。
{"title":"Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: a sub-analysis of the POPCORN registry.","authors":"Masahiko Fujihara, Mitsuyoshi Takahara, Yoshimitsu Soga, Osamu Iida, Daizo Kawasaki, Yusuke Tomoi, Yoshinori Tsubakimoto, Kenji Ogata, Eiji Karashima, Taku Kato, Yohei Kobayashi, Nobuhito Kaneko, Shinya Sasaki, Kei Ichihashi","doi":"10.1186/s42155-023-00390-x","DOIUrl":"10.1186/s42155-023-00390-x","url":null,"abstract":"<p><strong>Background: </strong>Drug-coated balloons (DCBs) have significantly changed endovascular therapy (EVT) for femoropopliteal artery (FPA) disease, in terms of the expansion of indications for EVT for symptomatic lower extremity arterial disease (LEAD). However, whether there is a difference in the performance among individual DCBs has not yet been fully discussed. The present sub-analysis of real-world data from a prospective trial of first-generation DCBs compared the clinical outcomes between high- and low-dose DCBs using propensity score matching methods. The primary endpoint was the restenosis-free and revascularization-free rates at 1 year.</p><p><strong>Results: </strong>We compared 592 pairs matched for patient and lesion characteristics using propensity score matching among a total of 2,507 cases with first-generation DCBs (592 and 1,808 cases in the Lutonix low-dose and In.PACT Admiral high-dose DCB groups, respectively). There were no differences in patient/lesion characteristics, procedural success rates, or complications between the two groups. First-generation low-dose DCB had significantly lower patency (73.3% [95% confidence interval, 69.6%-77.3%] in the low-dose DCB group versus 86.2% [84.1%-88.3%] in the high-dose DCB group; P < 0.001) and revascularization-free (84.9% [81.9%-88.1%] versus 92.5% [90.8%-94.1%]; P < 0.001) rates. Chronic kidney disease on dialysis, cilostazol use, anticoagulant use, and severe calcification had a significant interaction effect in the association (all P < 0.05).</p><p><strong>Conclusions: </strong>EVT to FPA with first-generation DCBs had inferior low-dose patency outcomes as compared with high-dose outcomes in the present cohort.</p><p><strong>Level of evidence: </strong>Sub analysis of a prospective multicenter study.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10339604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Occlusion of thoracic duct stent resulting in recurrent chyluria: role of renal-lymphatic fistula embolization. 胸导管支架闭塞导致乳糜尿复发:肾淋巴瘘栓塞的作用。
IF 1.2 Pub Date : 2023-08-07 DOI: 10.1186/s42155-023-00387-6
Tran Quoc Hoa, Nguyen Ngoc Cuong, Le Hoan, Nguyen Hoang, Hoang Long, Doan Tien Luu, Nguyen Cong Hoan

Background: Thoracic duct (TD) stenting is considered a treatment option for certain pathological conditions caused by TD obstruction, such as chyluria. Several studies have reported on the efficacy of TD stent treatment for both obstructive and leakage condition of TD, but few have evaluated the stent patency. This report aims to describe the patency of TD stent and the effectiveness of renal-lymphatic fistula embolization in the treatment of chyluria.

Case presentation: We report a case of chyluria treated by TD stent previously, stent was placed at the TD venous junction four months before the symptoms recurred. At the second intervention we found the stent was obstructed by debris. We recanalized the stent and successfully catheterised the microcatheter through the stent retrograde into the TD then into the renal-lymphatic fistula branch. After embolization of that abnormal branch, the recurrent chyluria was treated and no further episode of chyluria was occurred during 12 months follow up.

Conclusion: Stent in the TD may be occluded by debris. Embolization of renal-lymphatic fistula might be the most important treatment for spontaneous chyluria.

背景:胸导管(TD)支架置入术被认为是治疗某些病理条件引起的TD阻塞的选择,如乳糜尿。一些研究报道了TD支架治疗TD梗阻性和渗漏性的疗效,但很少有研究评估支架的通畅性。本报告旨在描述TD支架的通畅性和肾淋巴瘘栓塞治疗乳糜尿的效果。病例介绍:我们报告了一例乳糜尿患者,在症状复发前4个月,在TD静脉交界处放置了支架。在第二次介入时,我们发现支架被碎片堵塞了。我们重新通管支架,并成功地将微导管通过支架逆行插入TD,然后进入肾淋巴瘘分支。在对该异常分支进行栓塞治疗后,复发性乳糜尿得到治疗,在12个月的随访中没有再发生乳糜尿。结论:TD内支架可能被碎片堵塞。肾淋巴瘘栓塞可能是自发性乳糜尿最重要的治疗方法。
{"title":"Occlusion of thoracic duct stent resulting in recurrent chyluria: role of renal-lymphatic fistula embolization.","authors":"Tran Quoc Hoa, Nguyen Ngoc Cuong, Le Hoan, Nguyen Hoang, Hoang Long, Doan Tien Luu, Nguyen Cong Hoan","doi":"10.1186/s42155-023-00387-6","DOIUrl":"10.1186/s42155-023-00387-6","url":null,"abstract":"<p><strong>Background: </strong>Thoracic duct (TD) stenting is considered a treatment option for certain pathological conditions caused by TD obstruction, such as chyluria. Several studies have reported on the efficacy of TD stent treatment for both obstructive and leakage condition of TD, but few have evaluated the stent patency. This report aims to describe the patency of TD stent and the effectiveness of renal-lymphatic fistula embolization in the treatment of chyluria.</p><p><strong>Case presentation: </strong>We report a case of chyluria treated by TD stent previously, stent was placed at the TD venous junction four months before the symptoms recurred. At the second intervention we found the stent was obstructed by debris. We recanalized the stent and successfully catheterised the microcatheter through the stent retrograde into the TD then into the renal-lymphatic fistula branch. After embolization of that abnormal branch, the recurrent chyluria was treated and no further episode of chyluria was occurred during 12 months follow up.</p><p><strong>Conclusion: </strong>Stent in the TD may be occluded by debris. Embolization of renal-lymphatic fistula might be the most important treatment for spontaneous chyluria.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406733/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9965407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uterine artery embolization in Tanzania: a procedure with major public health implications. 坦桑尼亚子宫动脉栓塞:一项具有重大公共卫生影响的程序。
IF 1.2 Pub Date : 2023-08-07 DOI: 10.1186/s42155-023-00384-9
Balowa Musa, Jared Mark Alswang, Rose Di Ioia, Lydia Grubic, Azza Naif, Erick Michael Mbuguje, Victoria Vuong, Janice Newsome, Behnam Shaygi, Vijay Ramalingam, Fabian Max Laage Gaupp

Background: The burden of uterine fibroids is substantial in sub-Saharan Africa (SSA), with up to 80% of black women harboring them in their lifetime. While uterine artery embolization (UAE) has emerged as an effective alternative to surgery to manage this condition, the procedure is not available to the vast majority of women living in SSA due to limited access to interventional radiology (IR) in the region. One of the few countries in SSA now offering UAE in a public hospital setting is Tanzania. This study aims to assess the safety and effectiveness of UAE in this new environment.

Methods: From June 2019 to July 2022, a single-center, retrospective cohort study was conducted at Tanzania's first IR service on all patients who underwent UAE for the management of symptomatic fibroids or adenomyosis. Patients were selected for the procedure based on symptom severity, imaging findings, and medical management failure. Procedural technical success and adverse events were recorded for all UAEs. Self-reported symptom severity and volumetric response on imaging were compared between baseline and six-months post-procedure using paired sample t-tests.

Results: During the study period, 92.1% (n = 35/38) of patients underwent UAE for the management of symptomatic fibroids and 7.9% (n = 3/38) for adenomyosis. All (n = 38/38) were considered technically successful and one minor adverse event occurred (2.7%). Self-reported symptom-severity scores at six-months post-procedure decreased in all categories: abnormal uterine bleeding from 8.8 to 3.1 (-5.7), pain from 6.7 to 3.2 (-3.5), and bulk symptoms from 2.8 to 1 (-1.8) (p < 0.01). 100% of patients reported satisfaction with outcomes. Among the nine patients with follow-up imaging, there was a mean volumetric decrease of 35.5% (p = 0.109).

Conclusions: UAE for fibroids and adenomyosis can be performed with high technical success and low complication rates in a low-resource setting like Tanzania, resulting in significant symptom relief for patients. Building capacity for UAE has major public health implications not only for fibroids and adenomyosis, but can help address the region's leading cause of maternal mortality, postpartum hemorrhage.

背景:在撒哈拉以南非洲(SSA),子宫肌瘤的负担是巨大的,高达80%的黑人妇女在其一生中都有子宫肌瘤。虽然子宫动脉栓塞(UAE)已成为治疗这种疾病的有效替代手术,但由于该地区介入放射学(IR)的限制,绝大多数生活在SSA的妇女无法使用该手术。坦桑尼亚是SSA为数不多的在公立医院提供阿联酋服务的国家之一。本研究旨在评估阿联酋在这种新环境下的安全性和有效性。方法:2019年6月至2022年7月,在坦桑尼亚首个IR服务中心对所有接受阿联酋治疗症状性肌瘤或子宫腺肌症的患者进行了一项单中心回顾性队列研究。根据症状严重程度、影像学表现和医疗管理失败来选择患者。记录所有uae的手术技术成功和不良事件。采用配对样本t检验比较基线和手术后6个月自我报告的症状严重程度和容积反应。结果:在研究期间,92.1% (n = 35/38)的患者因症状性肌瘤而行UAE, 7.9% (n = 3/38)的患者因子宫腺肌症而行UAE。所有患者(n = 38/38)均被认为技术成功,发生1例轻微不良事件(2.7%)。术后6个月自我报告的症状严重程度评分在所有类别中均有所下降:异常子宫出血从8.8降至3.1(-5.7),疼痛从6.7降至3.2(-3.5),整体症状从2.8降至1 (-1.8)(p结论:在坦桑尼亚等资源匮乏的环境中,子宫肌瘤和子宫腺肌症的联合手术技术成功率高,并发症发生率低,可显著缓解患者的症状。阿联酋的能力建设不仅对肌瘤和bbb具有重大的公共卫生影响,而且可以帮助解决该地区孕产妇死亡的主要原因——产后出血。
{"title":"Uterine artery embolization in Tanzania: a procedure with major public health implications.","authors":"Balowa Musa, Jared Mark Alswang, Rose Di Ioia, Lydia Grubic, Azza Naif, Erick Michael Mbuguje, Victoria Vuong, Janice Newsome, Behnam Shaygi, Vijay Ramalingam, Fabian Max Laage Gaupp","doi":"10.1186/s42155-023-00384-9","DOIUrl":"10.1186/s42155-023-00384-9","url":null,"abstract":"<p><strong>Background: </strong>The burden of uterine fibroids is substantial in sub-Saharan Africa (SSA), with up to 80% of black women harboring them in their lifetime. While uterine artery embolization (UAE) has emerged as an effective alternative to surgery to manage this condition, the procedure is not available to the vast majority of women living in SSA due to limited access to interventional radiology (IR) in the region. One of the few countries in SSA now offering UAE in a public hospital setting is Tanzania. This study aims to assess the safety and effectiveness of UAE in this new environment.</p><p><strong>Methods: </strong>From June 2019 to July 2022, a single-center, retrospective cohort study was conducted at Tanzania's first IR service on all patients who underwent UAE for the management of symptomatic fibroids or adenomyosis. Patients were selected for the procedure based on symptom severity, imaging findings, and medical management failure. Procedural technical success and adverse events were recorded for all UAEs. Self-reported symptom severity and volumetric response on imaging were compared between baseline and six-months post-procedure using paired sample t-tests.</p><p><strong>Results: </strong>During the study period, 92.1% (n = 35/38) of patients underwent UAE for the management of symptomatic fibroids and 7.9% (n = 3/38) for adenomyosis. All (n = 38/38) were considered technically successful and one minor adverse event occurred (2.7%). Self-reported symptom-severity scores at six-months post-procedure decreased in all categories: abnormal uterine bleeding from 8.8 to 3.1 (-5.7), pain from 6.7 to 3.2 (-3.5), and bulk symptoms from 2.8 to 1 (-1.8) (p < 0.01). 100% of patients reported satisfaction with outcomes. Among the nine patients with follow-up imaging, there was a mean volumetric decrease of 35.5% (p = 0.109).</p><p><strong>Conclusions: </strong>UAE for fibroids and adenomyosis can be performed with high technical success and low complication rates in a low-resource setting like Tanzania, resulting in significant symptom relief for patients. Building capacity for UAE has major public health implications not only for fibroids and adenomyosis, but can help address the region's leading cause of maternal mortality, postpartum hemorrhage.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9967629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications in Interventional Radiology: the role of clinical governance and iterative hospital systems in quality improvement. 介入放射学的并发症:临床管理和迭代医院系统在质量改进中的作用。
IF 1.2 Pub Date : 2023-08-05 DOI: 10.1186/s42155-023-00388-5
Warren Clements, Jim Koukounaras

As modern Interventional Radiology (IR) evolves, and expands in scope and complexity, it will push the boundaries of existing literature. However, with all intervention comes risk and it is the shared judgement of the risk-benefit analysis which underpins the ethical and legal principles of care in IR.Complications in medicine are common, said to occur in 9.2% of in-hospital healthcare interactions. Healthcare complications also come at considerable cost. It is estimated that in the UK, prolonging hospital stays to manage complications can cost ₤2 billion per year.However, complications can't be viewed in isolation. Clinical governance is the umbrella within which complications are viewed. It can be defined as a broadly integrated and systematic approach to clinical care and accountability, that seeks to focus on quality of healthcare. This concept incorporates complications but acknowledges their interplay within a complex healthcare system in which negative adverse events are influenced by a range of intrinsic and extrinsic factors. It also includes the processes that result from monitoring and learning from complications, with feedback leading to systems-based improvements in care moving forward. The reality is that complications are uncommonly the result of medical negligence, but rather they are an unfortunate by-product of a healthcare industry with inherent risk.It is also important to remember that complications are not just a number on an audit sheet, but a potentially life-changing event for every patient that is affected. The events that follow immediately from an adverse outcome such as open disclosure are vital, and have implications for how that patient experiences healthcare and trusts healthcare professionals for the rest of their life. We must ensure that the patient and their family maintain trust in healthcare professionals into the future.Credentialling and accreditation are imperative for Interventional Radiologists to meet existing standards as well deal with challenging situations. These should integrate and align within the structure of an organization that has a safety and learning culture. It is the many layers of organisational clinical governance that arguably play the most important role in IR-related complications, rather than apportioning blame to an individual IR.

随着现代介入放射学(IR)的发展,范围和复杂性的扩大,它将推动现有文献的边界。然而,所有的干预都伴随着风险,风险-收益分析的共同判断是IR护理的伦理和法律原则的基础。医学上的并发症很常见,据说在9.2%的院内医疗互动中发生。医疗并发症也带来了相当大的成本。据估计,在英国,为了治疗并发症而延长住院时间每年要花费20亿英镑。然而,并发症不能孤立地看待。临床治理是观察并发症的保护伞。它可以被定义为临床护理和问责制的广泛综合和系统方法,旨在关注医疗保健质量。这一概念包括并发症,但承认它们在复杂的医疗保健系统中的相互作用,其中负面不良事件受到一系列内在和外在因素的影响。它还包括监测和从并发症中学习所产生的过程,其反馈导致基于系统的护理改进向前发展。现实情况是,并发症通常是医疗疏忽的结果,而是医疗保健行业固有风险的不幸副产品。同样重要的是要记住,并发症不仅仅是审计表上的数字,而是每个受影响患者潜在的改变生活的事件。不良结果(如公开披露)之后立即发生的事件至关重要,并影响患者在余生中如何体验医疗保健和信任医疗保健专业人员。我们必须确保病人及其家属在未来保持对医护人员的信任。资格认证和认证是必要的介入放射科医生,以满足现有的标准,以及处理具有挑战性的情况。这些应该在具有安全和学习文化的组织结构中整合和对齐。可以说,在IR相关并发症中发挥最重要作用的是多层组织临床治理,而不是将责任归咎于个人IR。
{"title":"Complications in Interventional Radiology: the role of clinical governance and iterative hospital systems in quality improvement.","authors":"Warren Clements, Jim Koukounaras","doi":"10.1186/s42155-023-00388-5","DOIUrl":"10.1186/s42155-023-00388-5","url":null,"abstract":"<p><p>As modern Interventional Radiology (IR) evolves, and expands in scope and complexity, it will push the boundaries of existing literature. However, with all intervention comes risk and it is the shared judgement of the risk-benefit analysis which underpins the ethical and legal principles of care in IR.Complications in medicine are common, said to occur in 9.2% of in-hospital healthcare interactions. Healthcare complications also come at considerable cost. It is estimated that in the UK, prolonging hospital stays to manage complications can cost ₤2 billion per year.However, complications can't be viewed in isolation. Clinical governance is the umbrella within which complications are viewed. It can be defined as a broadly integrated and systematic approach to clinical care and accountability, that seeks to focus on quality of healthcare. This concept incorporates complications but acknowledges their interplay within a complex healthcare system in which negative adverse events are influenced by a range of intrinsic and extrinsic factors. It also includes the processes that result from monitoring and learning from complications, with feedback leading to systems-based improvements in care moving forward. The reality is that complications are uncommonly the result of medical negligence, but rather they are an unfortunate by-product of a healthcare industry with inherent risk.It is also important to remember that complications are not just a number on an audit sheet, but a potentially life-changing event for every patient that is affected. The events that follow immediately from an adverse outcome such as open disclosure are vital, and have implications for how that patient experiences healthcare and trusts healthcare professionals for the rest of their life. We must ensure that the patient and their family maintain trust in healthcare professionals into the future.Credentialling and accreditation are imperative for Interventional Radiologists to meet existing standards as well deal with challenging situations. These should integrate and align within the structure of an organization that has a safety and learning culture. It is the many layers of organisational clinical governance that arguably play the most important role in IR-related complications, rather than apportioning blame to an individual IR.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404211/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9951795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transsplenic tract closure after transsplenic portalvenous access using gelfoam-based tract plugging. 经脾门静脉入路后用凝胶泡沫封堵经脾束。
IF 1.2 Pub Date : 2023-07-17 DOI: 10.1186/s42155-023-00383-w
Meine Tc, Kretschmann N, Yerdelen Ss, Wacker Fk, Meyer Bc, Hinrichs Jb

Background: To assess the feasibility and safety of a gelfoam torpedo plugging technique for embolization of the transsplenic access channel in adult patients following transvenous portal vein interventions.

Materials and methods: Between 09/2016 and 08/2021, an ultrasound guided transsplenic portalvenous access (TSPVA) was established in twenty-four adult patients with a 21-G needle and 4-F microsheath under ultrasound guidance. Afterwards, sheaths ranging from 4-F to 8-F were inserted as needed for the procedure. Following portal vein intervention, the splenic access tract was embolized with a gelfoam-based tract plugging (GFTP) technique. TSPVA and GFTP were performed twice in two patients. Patients' pre-interventional and procedural characteristics were analyzed to assess the feasibility and safety of the plugging technique according Cardiovascular and Interventional Radiological Society of Europe (CIRSE) classification system. Values are given as median (minimum;maximum). Subgroup analysis of intercostal vs. subcostal puncture site for TSPVA was performed using the two-sided Mann-Whitney-U test or Student's t-test and Fisher's exact test. Level of significance was p < 0.05.

Results: The study population's age was 56 (29;71) years and 54% were female patients. Primary liver disease was predominantly liver cirrhosis with 62% of the patients. Pre-interventional model for end-stage liver disease score was 9 (6;25), international normalized ratio was 1.15 (0.86;1.51), activated partial thromboplastin time was 33s (26s;52s) and platelet count was 88.000/µL (31.000;273.000/µL). Ascites was present in 76% of the cases. Craniocaudal spleen diameter was 17cm (10cm;25cm). Indication for TSPVA was assisted transjugular intrahepatic portosystemic shunt placement in 16 cases and revision in two cases, portal vein stent placement in five cases and variceal embolization in three cases. TSPVA was successfully established in all interventions; interventional success rate was 85% (22/26). The splenic access time was 33min (10min;133min) and the total procedure time was 208min (110min;429min). Splenic access was performed with a subcostal route in 11 interventions and with an intercostal route in 15 interventions. Final sheath size was 4-F in 17 cases, 5-F in three cases, 6-F in five cases, 7-F in two cases and 8-F in one case. A median of two gelfoam cubes was used for GFTP. TSPVA- and GFTP-related complications occurred in 4 of 26 interventions (15%) with a subcapsular hematoma of the spleen in two patients (CIRSE grade 1), access-related infection in one patient (CIRSE grade 3) and both in one patient (CIRSE grade 3). In detail, one access-related complication occurred in a patient with subcostal TSPVA (CIRSE grade 1 complication) and the other three complications occurred in patients with intercostal TSPVA (one CIRSE grade 1 complication and two CIRSE grade 3 complication) (p = 0.614). No pat

背景:评估明胶泡沫鱼雷封堵技术在成年患者经静脉门静脉介入后经脾通道栓塞的可行性和安全性。材料与方法:2016年9月至2021年8月,在超声引导下,用21-G针和4-F微鞘,对24例成人患者建立超声引导下经脾门静脉通道(TSPVA)。之后,根据需要插入4-F至8-F的鞘。门静脉介入后,用凝胶泡沫为基础的通道堵塞(GFTP)技术栓塞脾通路。2例患者行TSPVA和GFTP两次。根据欧洲心血管与介入放射学会(CIRSE)的分类系统,分析患者介入前和手术特点,评估封堵技术的可行性和安全性。数值以中位数(最小值;最大值)给出。采用双侧Mann-Whitney-U检验或Student's t检验和Fisher's精确检验对TSPVA肋间和肋下穿刺部位进行亚组分析。结果:研究人群年龄56岁(29;71)岁,女性患者占54%。原发性肝病以肝硬化为主,占62%。终末期肝病介入前模型评分为9分(6;25分),国际标准化比值为1.15分(0.86;1.51分),活化部分凝血活素时间为33秒(26;52秒),血小板计数为88.000/µL(31.000;273.000/µL)。76%的病例出现腹水。颅趾脾直径17cm (10cm;25cm)。经颈静脉肝内门静脉分流术16例,翻修术2例,门静脉支架置入术5例,静脉曲张栓塞术3例。在所有干预措施中均成功建立了TSPVA;介入成功率85%(22/26)。脾通道时间分别为33min (10min;133min),总手术时间分别为208min (110min;429min)。脾通路经肋下通路11例,经肋间通路15例。最终鞘层尺寸为4-F 17例,5-F 3例,6-F 5例,7-F 2例,8-F 1例。GFTP采用两个明胶泡沫立方体的中位数。26例干预中有4例(15%)发生TSPVA和gftp相关并发症,其中2例患者(CIRSE 1级)出现脾脏包膜下血肿,1例患者(CIRSE 3级)出现通路相关感染,1例患者(CIRSE 3级)出现TSPVA和gftp相关并发症。肋下TSPVA患者出现1例通路相关并发症(CIRSE 1级并发症),肋间TSPVA患者出现3例并发症(1例CIRSE 1级并发症和2例CIRSE 3级并发症)(p = 0.614)。无患者因穿刺道出血需要介入或手术治疗。结论:在经皮门静脉介入治疗的成人患者中,采用凝胶泡沫封堵穿刺道是可行且安全的。由于缺乏大出血并发症和明胶海绵的完全吸收,使其成为经颈静脉和经肝进入和经脾途径再次介入的安全选择。
{"title":"Transsplenic tract closure after transsplenic portalvenous access using gelfoam-based tract plugging.","authors":"Meine Tc,&nbsp;Kretschmann N,&nbsp;Yerdelen Ss,&nbsp;Wacker Fk,&nbsp;Meyer Bc,&nbsp;Hinrichs Jb","doi":"10.1186/s42155-023-00383-w","DOIUrl":"https://doi.org/10.1186/s42155-023-00383-w","url":null,"abstract":"<p><strong>Background: </strong>To assess the feasibility and safety of a gelfoam torpedo plugging technique for embolization of the transsplenic access channel in adult patients following transvenous portal vein interventions.</p><p><strong>Materials and methods: </strong>Between 09/2016 and 08/2021, an ultrasound guided transsplenic portalvenous access (TSPVA) was established in twenty-four adult patients with a 21-G needle and 4-F microsheath under ultrasound guidance. Afterwards, sheaths ranging from 4-F to 8-F were inserted as needed for the procedure. Following portal vein intervention, the splenic access tract was embolized with a gelfoam-based tract plugging (GFTP) technique. TSPVA and GFTP were performed twice in two patients. Patients' pre-interventional and procedural characteristics were analyzed to assess the feasibility and safety of the plugging technique according Cardiovascular and Interventional Radiological Society of Europe (CIRSE) classification system. Values are given as median (minimum;maximum). Subgroup analysis of intercostal vs. subcostal puncture site for TSPVA was performed using the two-sided Mann-Whitney-U test or Student's t-test and Fisher's exact test. Level of significance was p < 0.05.</p><p><strong>Results: </strong>The study population's age was 56 (29;71) years and 54% were female patients. Primary liver disease was predominantly liver cirrhosis with 62% of the patients. Pre-interventional model for end-stage liver disease score was 9 (6;25), international normalized ratio was 1.15 (0.86;1.51), activated partial thromboplastin time was 33s (26s;52s) and platelet count was 88.000/µL (31.000;273.000/µL). Ascites was present in 76% of the cases. Craniocaudal spleen diameter was 17cm (10cm;25cm). Indication for TSPVA was assisted transjugular intrahepatic portosystemic shunt placement in 16 cases and revision in two cases, portal vein stent placement in five cases and variceal embolization in three cases. TSPVA was successfully established in all interventions; interventional success rate was 85% (22/26). The splenic access time was 33min (10min;133min) and the total procedure time was 208min (110min;429min). Splenic access was performed with a subcostal route in 11 interventions and with an intercostal route in 15 interventions. Final sheath size was 4-F in 17 cases, 5-F in three cases, 6-F in five cases, 7-F in two cases and 8-F in one case. A median of two gelfoam cubes was used for GFTP. TSPVA- and GFTP-related complications occurred in 4 of 26 interventions (15%) with a subcapsular hematoma of the spleen in two patients (CIRSE grade 1), access-related infection in one patient (CIRSE grade 3) and both in one patient (CIRSE grade 3). In detail, one access-related complication occurred in a patient with subcostal TSPVA (CIRSE grade 1 complication) and the other three complications occurred in patients with intercostal TSPVA (one CIRSE grade 1 complication and two CIRSE grade 3 complication) (p = 0.614). No pat","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9833136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The ViaHole technique: a novel approach for recanalizing major side branch occluded by Viabahn stent-graft. ViaHole技术:Viabahn支架再通主要侧支的新方法。
IF 1.2 Pub Date : 2023-07-15 DOI: 10.1186/s42155-023-00385-8
Takuya Haraguchi, Masanaga Tsujimoto, Ryo Otake, Yoshifumi Kashima, Katsuhiko Sato, Tsutomu Fujita

Introduction: In managing arterial rupture, stent-graft implantation may cause limb ischemia by crossing a major branch for hemostasis. The ViaHole technique could circumvent a major branch occlusion.

Materials and methods: The process involved advancing retrograde devices into an occluded major branch by the stent-graft implantation to reach the outer surface of the stent-graft, puncturing the stent-graft with a 20-gauge needle to touch the retrograde device, manipulating the guidewire through the needle hole and externalizing it, advancing the microcatheter into the proximal lumen, catching the microcatheter using an antegrade 4-Fr catheter, inserting an antegrade guidewire into the retrograde microcatheter to cross the stent-graft hole, dilating the lesion and stent-graft hole using a 3.0-mm balloon, and ensuring hemostasis at the puncture site.

Results: A 72-year-old male with a history of stent-grafted treatment for right popliteal aneurysm presented with acute limb ischemia (ALI). The occlusion spanned distal superficial femoral artery to the below-the-knee arteries. Hemostasis was achieved after an unintentional rupture of the proximal posterior tibial artery during surgical thrombectomy by implanting endoluminal stent-grafts instead of surgical bypass due to no distal anastomosis site. However, recurrent ALI occurred three months later. Surgical bypass was again deemed unfeasible due to no run-off. Unsuccessful recanalization attempts of the bilateral tibial arteries led us to perform the ViaHole technique to recanalize the peroneal artery occlusion. Finally. successful revascularization was achieved, and 1-year patency was confirmed.

Conclusions: The ViaHole technique may be valuable for revascularizing a major side branch occluded by stent-graft implantation.

简介:在处理动脉破裂时,支架植入术可能会导致肢体缺血,因为它会穿过动脉主干进行止血。ViaHole技术可以避免主要分支闭塞。材料和方法:这个过程包括通过支架植入将逆行装置推进到闭塞的主要分支到达支架移植物的外表面,用20号针穿刺支架移植物以接触逆行装置,通过针孔操纵导丝并将其外化,将微导管推进到近端管腔,使用顺行4-Fr导管捕捉微导管。将顺行导丝插入逆行微导管穿过支架-移植物孔,用3.0 mm球囊扩张病变和支架-移植物孔,确保穿刺部位止血。结果:男性,72岁,曾行右腘动脉瘤支架置入术,急性肢体缺血(ALI)。闭塞跨越股浅动脉远端至膝下动脉。由于没有远端吻合口,在手术取栓过程中,由于胫骨后近端动脉意外破裂,通过植入腔内支架代替手术旁路,实现了止血。然而,3个月后再次发生ALI。手术旁路再次被认为是不可行的,因为没有径流。由于双侧胫骨动脉再通失败,我们采用ViaHole技术对腓骨动脉闭塞进行再通。最后。血运重建成功,1年通畅。结论:ViaHole技术可用于支架植入阻塞的主要侧支血运重建。
{"title":"The ViaHole technique: a novel approach for recanalizing major side branch occluded by Viabahn stent-graft.","authors":"Takuya Haraguchi,&nbsp;Masanaga Tsujimoto,&nbsp;Ryo Otake,&nbsp;Yoshifumi Kashima,&nbsp;Katsuhiko Sato,&nbsp;Tsutomu Fujita","doi":"10.1186/s42155-023-00385-8","DOIUrl":"https://doi.org/10.1186/s42155-023-00385-8","url":null,"abstract":"<p><strong>Introduction: </strong>In managing arterial rupture, stent-graft implantation may cause limb ischemia by crossing a major branch for hemostasis. The ViaHole technique could circumvent a major branch occlusion.</p><p><strong>Materials and methods: </strong>The process involved advancing retrograde devices into an occluded major branch by the stent-graft implantation to reach the outer surface of the stent-graft, puncturing the stent-graft with a 20-gauge needle to touch the retrograde device, manipulating the guidewire through the needle hole and externalizing it, advancing the microcatheter into the proximal lumen, catching the microcatheter using an antegrade 4-Fr catheter, inserting an antegrade guidewire into the retrograde microcatheter to cross the stent-graft hole, dilating the lesion and stent-graft hole using a 3.0-mm balloon, and ensuring hemostasis at the puncture site.</p><p><strong>Results: </strong>A 72-year-old male with a history of stent-grafted treatment for right popliteal aneurysm presented with acute limb ischemia (ALI). The occlusion spanned distal superficial femoral artery to the below-the-knee arteries. Hemostasis was achieved after an unintentional rupture of the proximal posterior tibial artery during surgical thrombectomy by implanting endoluminal stent-grafts instead of surgical bypass due to no distal anastomosis site. However, recurrent ALI occurred three months later. Surgical bypass was again deemed unfeasible due to no run-off. Unsuccessful recanalization attempts of the bilateral tibial arteries led us to perform the ViaHole technique to recanalize the peroneal artery occlusion. Finally. successful revascularization was achieved, and 1-year patency was confirmed.</p><p><strong>Conclusions: </strong>The ViaHole technique may be valuable for revascularizing a major side branch occluded by stent-graft implantation.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9827347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Complex endoleak treatment after failed endovascular aortic repair. 血管内主动脉修复失败后的复杂内漏治疗。
IF 1.2 Pub Date : 2023-07-05 DOI: 10.1186/s42155-023-00381-y
Jan Raupach, Jan Masek, Sindharta Venugopal, Ondrej Renc, Michal Lesko, Maly Radovan

Background: Endovascular aneurysm repair (EVAR) has created new possibilities for patients with abdominal aortic aneurysms (AAAs), and in recent years it has become tremendously popular. Use of EVAR in selected groups of patients allows mortality and morbidity to be reduced in comparison to open repair. However, complications such as endoleaks (ELs) can be of great concern and warrant urgent therapy to prevent sac rupture.

Case presentation: The case report presents urgent endovascular treatment of a high-risk type IA EL in a polymorbid 68-year-old patient 7 years after primary EVAR. The principle of treatment was parallel implantation of the proximal SG extension with the renal SG into the right renal artery (chimney technique). The subsequent type II collateral EL was treated by direct transabdominal AAA sac puncture and thrombin embolization.

Conclusion: EL can be a cause for urgent intervention, but specific anatomic features often require specialized SG types which are not readily available. The chimney technique allows the use of immediately available stent grafts to address endoleak in the setting of impending abdominal aneurysm rupture.

背景:血管内动脉瘤修复(EVAR)为腹主动脉瘤(AAAs)患者创造了新的可能性,近年来它变得非常流行。与开放式修复相比,在选定的患者组中使用EVAR可以降低死亡率和发病率。然而,并发症如内漏(el)可能是非常值得关注的,需要紧急治疗以防止囊破裂。病例介绍:病例报告介绍了一名68岁多病患者在原发性EVAR后7年的高风险IA型EL的紧急血管内治疗。治疗原则是将近端SG延伸与肾SG平行植入右肾动脉(烟囱技术)。随后的II型侧支EL采用直接经腹AAA囊穿刺和凝血酶栓塞治疗。结论:EL可能是紧急干预的原因,但特定的解剖特征通常需要专门的SG类型,而这种类型不易获得。烟囱技术允许使用立即可用的支架移植物来解决腹内动脉瘤即将破裂的情况下的内漏。
{"title":"Complex endoleak treatment after failed endovascular aortic repair.","authors":"Jan Raupach,&nbsp;Jan Masek,&nbsp;Sindharta Venugopal,&nbsp;Ondrej Renc,&nbsp;Michal Lesko,&nbsp;Maly Radovan","doi":"10.1186/s42155-023-00381-y","DOIUrl":"https://doi.org/10.1186/s42155-023-00381-y","url":null,"abstract":"<p><strong>Background: </strong>Endovascular aneurysm repair (EVAR) has created new possibilities for patients with abdominal aortic aneurysms (AAAs), and in recent years it has become tremendously popular. Use of EVAR in selected groups of patients allows mortality and morbidity to be reduced in comparison to open repair. However, complications such as endoleaks (ELs) can be of great concern and warrant urgent therapy to prevent sac rupture.</p><p><strong>Case presentation: </strong>The case report presents urgent endovascular treatment of a high-risk type IA EL in a polymorbid 68-year-old patient 7 years after primary EVAR. The principle of treatment was parallel implantation of the proximal SG extension with the renal SG into the right renal artery (chimney technique). The subsequent type II collateral EL was treated by direct transabdominal AAA sac puncture and thrombin embolization.</p><p><strong>Conclusion: </strong>EL can be a cause for urgent intervention, but specific anatomic features often require specialized SG types which are not readily available. The chimney technique allows the use of immediately available stent grafts to address endoleak in the setting of impending abdominal aneurysm rupture.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9803618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of chronic total occlusion in popliteal artery recanalized by double snare piercing technique. 双圈套穿刺技术再通腘动脉慢性全闭塞1例。
IF 1.2 Pub Date : 2023-06-22 DOI: 10.1186/s42155-023-00380-z
Hirokazu Miyashita, Kazuki Tobita, Syuhei Uchida, Eiji Koyama, Yusuke Tamaki, Takayoshi Yamashita, Shigeru Saito

Background: Although majority of cases with chronic total occlusion (CTO) in femoro-popliteal lesion were treated with antegrade approach only, some lesions require alternative approach due to its complexity. Bi-directional approach is useful on endovascular therapy (EVT) for CTO; however guidewire passage through the lesion is impossible in some challenging cases. The present case shows a successful re-entry technique utilizing two snare catheters from an antegrade and retrograde access site (double snare piecing technique).

Case presentation: A 79-year-old woman with right leg intermittent claudication (Rutherford category IV), who had undergone unsuccessful EVT for popliteal CTO, required another EVT for the worsening symptom. Following the failed conventional crossing technique (wire knuckle technique, intravascular-ultrasound-guided wiring, and controlled antegrade and retrograde subintimal tracking technique), two snare catheters were placed and the snare loops were pierced by a puncture needle percutaneously. After an 0.014 wire was inserted into the needle, the needle was withdrawn. The wire was pulled from the retrograde side and was externalized. Then, the antegrade snare catheter was pulled and externalized, to make the wire across the lesion. After that, a microcatheter was advanced along the externalized wire from the retrograde side and cross the lesion. The wire was replaced with a new wire, which completely created pull-through system. After the hemostasis by balloon inflation and lesion preparation, this procedure was completed with an endoluminal-covered stent and two inter-woven stents. The re-entry site was covered by the inter-woven stent. Her symptoms improved after the procedure, and the lesion has not developed restenosis at 2-years follow-up.

Conclusions: This re-entry technique of puncturing two snare loops (double snare piercing technique) might be effective for achieving successful passage through challenging femoropopliteal CTO cases.

背景:虽然大多数股骨-腘窝病变慢性全闭塞(CTO)仅行顺行入路治疗,但由于其复杂性,一些病变需要选择其他入路。双向入路在CTO血管内治疗(EVT)中的应用然而,在一些具有挑战性的病例中,导丝通过病变是不可能的。本病例展示了一种成功的再入技术,利用来自顺行和逆行通道的两根诱捕导管(双诱捕缝合技术)。病例介绍:一名79岁女性右腿间歇性跛行(Rutherford IV类),因腘窝CTO行EVT治疗失败,需再次行EVT治疗症状恶化。在失败的传统交叉技术(钢丝关节技术,血管内超声引导下的布线,控制顺、逆行内膜下跟踪技术)之后,放置两个圈套导管,并用穿刺针经皮穿刺圈套环。在将0.014的金属丝插入针头后,取出针头。金属丝从逆行侧拔出并外化。然后,将顺行陷阱导管拉出并外化,使导线穿过病变。之后,从逆行侧沿外化导线推进微导管并穿过病变。电线被替换成新的电线,这完全创造了拉穿系统。在球囊膨胀止血和病变准备后,使用腔内覆盖支架和两个交织支架完成该手术。再入部位被交织支架覆盖。术后症状改善,随访2年,病灶未发生再狭窄。结论:双圈套穿刺技术可有效通过具有挑战性的股腘动脉CTO病例。
{"title":"A case of chronic total occlusion in popliteal artery recanalized by double snare piercing technique.","authors":"Hirokazu Miyashita,&nbsp;Kazuki Tobita,&nbsp;Syuhei Uchida,&nbsp;Eiji Koyama,&nbsp;Yusuke Tamaki,&nbsp;Takayoshi Yamashita,&nbsp;Shigeru Saito","doi":"10.1186/s42155-023-00380-z","DOIUrl":"https://doi.org/10.1186/s42155-023-00380-z","url":null,"abstract":"<p><strong>Background: </strong>Although majority of cases with chronic total occlusion (CTO) in femoro-popliteal lesion were treated with antegrade approach only, some lesions require alternative approach due to its complexity. Bi-directional approach is useful on endovascular therapy (EVT) for CTO; however guidewire passage through the lesion is impossible in some challenging cases. The present case shows a successful re-entry technique utilizing two snare catheters from an antegrade and retrograde access site (double snare piecing technique).</p><p><strong>Case presentation: </strong>A 79-year-old woman with right leg intermittent claudication (Rutherford category IV), who had undergone unsuccessful EVT for popliteal CTO, required another EVT for the worsening symptom. Following the failed conventional crossing technique (wire knuckle technique, intravascular-ultrasound-guided wiring, and controlled antegrade and retrograde subintimal tracking technique), two snare catheters were placed and the snare loops were pierced by a puncture needle percutaneously. After an 0.014 wire was inserted into the needle, the needle was withdrawn. The wire was pulled from the retrograde side and was externalized. Then, the antegrade snare catheter was pulled and externalized, to make the wire across the lesion. After that, a microcatheter was advanced along the externalized wire from the retrograde side and cross the lesion. The wire was replaced with a new wire, which completely created pull-through system. After the hemostasis by balloon inflation and lesion preparation, this procedure was completed with an endoluminal-covered stent and two inter-woven stents. The re-entry site was covered by the inter-woven stent. Her symptoms improved after the procedure, and the lesion has not developed restenosis at 2-years follow-up.</p><p><strong>Conclusions: </strong>This re-entry technique of puncturing two snare loops (double snare piercing technique) might be effective for achieving successful passage through challenging femoropopliteal CTO cases.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287857/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9709819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt (PVR-TIPS) with superior mesenteric vein access and balloon-assisted shunt placement. 门静脉再通-经颈静脉肝内门静脉系统分流术(PVR-TIPS)与肠系膜上静脉通路和球囊辅助分流放置。
IF 1.2 Pub Date : 2023-06-08 DOI: 10.1186/s42155-023-00379-6
Cornelia L A Dewald, Frank K Wacker, Benjamin Maasoumy, Jan B Hinrichs

Background: To report the technique and outcome of ultrasound-guided percutaneous access to the superior mesenteric vein (SMV) for balloon-assisted portal vein recanalization-transjugular intrahepatic portosystemic shunt (PVR-TIPS) in a patient with chronic portal venous and splenic vein occlusion.

Case presentation: A 51-year-old, non-cirrhotic patient with severe portal hypertension was admitted for PVR-TIPS. Neither splenic nor hepatic access was feasible due to chronic portal and splenic vein occlusion. Percutaneous ultrasound-guided direct puncture of the SMV was performed to obtain access for balloon-assisted PVR-TIPS. The transmesenteric approach in combination with a balloon puncture technique for PVR-TIPS was successful, and no immediate complications were observed post-procedure. The subsequent follow-up exams showed patent TIPS and SMV without signs of intraabdominal hemorrhage.

Conclusion: Percutaneous ultrasound-guided superior mesenteric vein access for balloon-assisted PVR-TIPS is a feasible option in cases where hepatic or splenic access is not.

背景:报道超声引导下经皮经肠系膜上静脉(SMV)球囊辅助门静脉再通-经颈静脉肝内门静脉系统分流术(pvrtips)治疗慢性门静脉和脾静脉闭塞患者的技术和结果。病例介绍:一名51岁非肝硬化严重门静脉高压症患者因PVR-TIPS入院。由于慢性门静脉和脾静脉阻塞,脾和肝通路均不可行。经皮超声引导下直接穿刺SMV以获得球囊辅助PVR-TIPS的通路。经肠系膜入路联合球囊穿刺技术治疗PVR-TIPS是成功的,术后未观察到立即并发症。随后的随访检查显示TIPS和SMV未见腹内出血迹象。结论:经皮超声引导肠系膜上静脉进入球囊辅助PVR-TIPS是一种可行的选择,在肝或脾不能进入的情况下。
{"title":"Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt (PVR-TIPS) with superior mesenteric vein access and balloon-assisted shunt placement.","authors":"Cornelia L A Dewald,&nbsp;Frank K Wacker,&nbsp;Benjamin Maasoumy,&nbsp;Jan B Hinrichs","doi":"10.1186/s42155-023-00379-6","DOIUrl":"https://doi.org/10.1186/s42155-023-00379-6","url":null,"abstract":"<p><strong>Background: </strong>To report the technique and outcome of ultrasound-guided percutaneous access to the superior mesenteric vein (SMV) for balloon-assisted portal vein recanalization-transjugular intrahepatic portosystemic shunt (PVR-TIPS) in a patient with chronic portal venous and splenic vein occlusion.</p><p><strong>Case presentation: </strong>A 51-year-old, non-cirrhotic patient with severe portal hypertension was admitted for PVR-TIPS. Neither splenic nor hepatic access was feasible due to chronic portal and splenic vein occlusion. Percutaneous ultrasound-guided direct puncture of the SMV was performed to obtain access for balloon-assisted PVR-TIPS. The transmesenteric approach in combination with a balloon puncture technique for PVR-TIPS was successful, and no immediate complications were observed post-procedure. The subsequent follow-up exams showed patent TIPS and SMV without signs of intraabdominal hemorrhage.</p><p><strong>Conclusion: </strong>Percutaneous ultrasound-guided superior mesenteric vein access for balloon-assisted PVR-TIPS is a feasible option in cases where hepatic or splenic access is not.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2023-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9963948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
CVIR Endovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1